Prurigo Nodularis at Ultra-High-Frequency Ultrasound [PDF]
DiagnosticsHere, we describe the case of a 48-year-old female patient with prurigo nodularis, where B-mode and color-Doppler ultrasound of one nodule was performed; this revealed hypoechoic dermal and hyperechoic epidermal thickening with lesion hypervascularity ...
Alessandra Michelucci +11 more
doaj +2 more sources
Tofacitinib for Prurigo Nodularis: A Case Report
Clinical, Cosmetic and Investigational Dermatology, 2022 Changlan Peng,1 Chunxiao Li,2 Yingying Zhou,1 Qiuyue Wang,1 Ping Xie,1 Tianhao Li,2,* Pingsheng Hao2,* 1Department of Dermatology, Chengdu University of Traditional Chinese Medicine, Chengdu, People’s Republic of China; 2Department of Dermatology,
Ping-Sheng Hao +2 more
exaly +2 more sources
Successful treatment of refractory prurigo nodularis with abrocitinib
Clinical Case Reports (discontinued)Key Clinical Message Prurigo nodularis is frequently difficult to manage with conventional therapy. Given the pathogenesis and refractory nature, we demonstrate a case in which inhibition of JAK–STAT signaling may significantly improve prurigo nodularis.
Zhenzhen Wu
exaly +2 more sources
Dupilumab for the treatment of prurigo nodularis: A systematic review
Frontiers in Immunology, 2023 BackgroundConventional treatment techniques have limited efficacy and more side effects in the treatment of prurigo nodularis. The better alternative treatment option for better outcomes of the disease is dupilumab.ObjectiveThe objective of this study ...
Zhang Litao
exaly +3 more sources
Cost-effectiveness Analysis of Dupilumab for the Treatment of Adult Patients with Severe Prurigo Nodularis in Italy [PDF]
Acta Dermato-VenereologicaPrurigo nodularis is characterized by intensely pruritic nodules that significantly impact patients’ quality of life. This study aims to evaluate the cost-effectiveness of dupilumab compared with the best supportive care for the treatment of severe ...
Cataldo Patruno +6 more
doaj +2 more sources
Safety, Pharmacokinetics, and Efficacy of 1.5% Ruxolitinib Gel (HDM3010) in Adult Patients with Prurigo Nodularis: A Phase I/II, Randomized, Double-Blind, Vehicle-Controlled Multicenter Clinical Trial [PDF]
Dermatology and TherapyIntroduction Prurigo nodularis (PN) is a chronic inflammatory dermatosis with severe, persistent pruritus and limited effective therapies. Janus kinase (JAK) inhibition has emerged as a targeted strategy for PN.
Chao Wu +28 more
doaj +2 more sources
Successful Treatment of Pediatric Atopic Prurigo Nodularis with Dupilumab [PDF]
Clinical, Cosmetic and Investigational DermatologyYuping Zhang,* Lizhu Liang,* Chen Li Department of Dermatology, Zhongshan City People’s Hospital, Zhongshan City, Guangdong Province, 528403, People’s Republic of China*These authors contributed equally to this workCorrespondence:
Zhang Y, Liang L, Li C
doaj +2 more sources
Immunotargets and Therapy for Prurigo Nodularis
ImmunoTargets and Therapy, 2022 Angelina Labib, Teresa Ju, Ashley Vander Does, Gil Yosipovitch Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery and Miami Itch Center, University of Miami Miller School of Medicine, Miami, FL, USACorrespondence: Gil Yosipovitch, Dr ...
, TERESA Ju, Angelina Labib
exaly +2 more sources
Effective Treatment of Prurigo Nodularis With Oral Tofacitinib: A Case Report [PDF]
Clinical Case ReportsRecent advancements in understanding the potential pathogenesis of prurigo nodularis (PN) have paved the way for the development of new, targeted therapies.
Nikoo Mozafari
doaj +2 more sources
Acta Dermato-Venereologica, 2022 While dialysis is linked with prurigo nodularis, little is known about the impact of non-dialysis chronic kidney disease on prurigo nodularis. The influence of chronic kidney disease on development of prurigo nodularis was measured using the Korean ...
Hei Sung Kim +2 more
doaj +1 more source